Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Prioty Islam, David Rizzieri, Chenyu Lin, Carlos de Castro, Louis Diehl, Zhiguo Li, Joseph Moore, Tod Morris & Anne Beaven. (2021) Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Cancer Investigation 39:10, pages 871-879.
Read now
Read now
Tanya Siddiqi, Paul Frankel, Jan H. Beumer, Brian F. Kiesel, Susan Christner, Chris Ruel, Joo Y. Song, Robert Chen, Kevin R. Kelly, Sikander Ailawadhi, Paul Kaesberg, Leslie Popplewell, Sandrine Puverel, Richard Piekarz, Stephen J. Forman & Edward M. Newman. (2020) Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies. Leukemia & Lymphoma 61:2, pages 309-317.
Read now
Read now
Bolun Wang, Hui Lyu, Shanshan Pei, Deye Song, Jiangdong Ni & Bolin Liu. (2018) Cladribine in combination with entinostat synergistically elicits anti-proliferative/anti-survival effects on multiple myeloma cells. Cell Cycle 17:8, pages 985-996.
Read now
Read now
Articles from other publishers (16)
Suvankar Banerjee, Sandip Kumar BaidyaNilanjan Adhikari, Tarun Jha & Balaram Ghosh. (2023) Hydrazides as Potential HDAC Inhibitors: Structure-activity
Relationships and Biological Implications. Current Topics in Medicinal Chemistry 23:25, pages 2343-2372.
Crossref
Crossref
Jinghong Chen, Zhixiang Zuo, Yan Gao, Xiaosai Yao, Peiyong Guan, Yali Wang, Zhimei Li, Zhilong Liu, Jing Han Hong, Peng Deng, Jason Yongsheng Chan, Daryl Ming Zhe Cheah, Jingquan Lim, Kelila Xin Ye Chai, Burton Kuan Hui Chia, Jane Wan Lu Pang, Joanna Koh, Dachuan Huang, Haixia He, Yichen Sun, Lizhen Liu, Shini Liu, Yuhua Huang, Xiaoxiao Wang, Hua You, Sahil Ajit Saraf, Nicholas Francis Grigoropoulos, Xiaoqiu Li, Jinxin Bei, Tiebang Kang, Soon Thye Lim, Bin Tean Teh, Huiqiang Huang, Choon Kiat Ong & Jing Tan. (2023) Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide. Clinical Epigenetics 15:1.
Crossref
Crossref
Yongfang Wang & Huiying Wang. (2022) The emerging role of histone deacetylase 1 in allergic diseases. Frontiers in Immunology 13.
Crossref
Crossref
Beatrice Calciolari, Greta Scarpinello, Laura Quotti Tubi, Francesco Piazza & Alessandro Carrer. (2022) Metabolic control of epigenetic rearrangements in B cell pathophysiology. Open Biology 12:5.
Crossref
Crossref
Michael Northend & William Townsend. (2021) Novel Therapy Approaches to Follicular Lymphoma. Drugs 81:4, pages 453-469.
Crossref
Crossref
Azra Anjum, Humaira Farooqi, MZ Abdin & AshokKumar Tiwari. (2021) Combinatorial effect of Macrotyloma uniflorum (Lam.) Verdc. seed extract and vorinostat (suberoylanilide hydroxamic acid) in human leukemia cells. Pharmacognosy Magazine 17:6, pages 213.
Crossref
Crossref
Lulu Liu, Jingjing Zhang, Xianning Zhang, Panpan Cheng, Lei Liu, Qian Huang, Haihui Liu, Saisai Ren, Peng Wei, Cuiling Wang, Cuiyun Dou, Lulu Chen, Xin Liu, Hao Zhang & Mingtai Chen. (2020) HMGB1: an important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target. Journal of Molecular Medicine 99:1, pages 107-118.
Crossref
Crossref
Babu Gajendran, Krishnapriya M. Varier, Wuling Liu, Chunlin Wang, Klarke M. Sample, Eldad Zacksenhaus, Cui Juiwei, LieJun Huang, XiaoJiang Hao & Yaacov Ben-David. (2020) A C21-steroidal derivative suppresses T-cell lymphoma in mice by inhibiting SIRT3 via SAP18-SIN3. Communications Biology 3:1.
Crossref
Crossref
Kenneth Lundstrom. (2019) Epigenetics, Nutrition, Disease and Drug Development. Current Drug Discovery Technologies 16:4, pages 386-391.
Crossref
Crossref
Yong-Tao Duan, Chetan B. Sangani, Wei Liu, Kunjal V. Soni & Yongfang Yao. (2019) New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics. Current Topics in Medicinal Chemistry 19:12, pages 972-994.
Crossref
Crossref
Matthew J. Barth & Veronique Minard‐Colin. (2019) Novel targeted therapeutic agents for the treatment of childhood, adolescent and young adult non‐Hodgkin lymphoma. British Journal of Haematology 185:6, pages 1111-1124.
Crossref
Crossref
Dan Yang, Wei-Ping Zhang, Jian-Min Yang, Miao-Xia He, Chao Cheng & Jie Chen. (2018) Secondary skin involvement in gastric diffuse large B-cell lymphoma treated with chidamide. Medicine 97:49, pages e13093.
Crossref
Crossref
Bo Jing, Jin Jin, Rufang Xiang, Meng Liu, Li Yang, Yin Tong, Xinhua Xiao, Hu Lei, Wei Liu, Hanzhang Xu, Jiong Deng, Li Zhou & Yingli Wu. (2018) Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition. Cell Death & Disease 9:6.
Crossref
Crossref
Sheng Yang, Peng Nan, Chunxiao Li, Feng Lin, Hui Li, Ting Wang, Chunxia Zhou, Xueyan Zhang, Xiting Meng, Haili Qian, Haijuan Wang & Mei Dong. (2018) Inhibitory effect of chidamide on the growth of human adenoid cystic carcinoma cells. Biomedicine & Pharmacotherapy 99, pages 608-614.
Crossref
Crossref
Benet Pera, Jan Krumsiek, Sarit E. Assouline, Rossella Marullo, Jayeshkumar Patel, Jude M. Phillip, Lidia Román, Koren K. Mann & Leandro Cerchietti. (2018) Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway. EBioMedicine 28, pages 80-89.
Crossref
Crossref
Christine Mauz-Körholz, Natascha Ströter, Julia Baumann, Ante Botzen, Katharina Körholz & Dieter Körholz. (2017) Pharmacotherapeutic Management of Pediatric Lymphoma. Pediatric Drugs 20:1, pages 43-57.
Crossref
Crossref